Of interest and article archive

Here you will find selected articles from our archive.
For historical articles, please see here.

Go back

January 21, 2026

Thor Medical ASA – Share Option grant

January 6, 2026

Thor Medical – Issuance of shares to executive member under incentive program

December 23, 2025

Thor Medical reaches key construction milestones at AlphaOne plant

December 4, 2025

RadioMedix and Thor Medical enter supply agreement for thorium-228

November 20, 2025

Thor Medical ASA – New share capital registered

November 20, 2025

Thor Medical enters supply agreement with NucliThera for thorium-228

November 18, 2025

Thor Medical strengthens executive team to realise leadership ambitions in targeted alpha therapies

November 11, 2025

Thor Medical – Issuance of RSU shares to members of the board

November 6, 2025

Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thorium-228

August 29, 2025

Thor Medical ASA interim results for 1H 2025 – strong operational and commercial progress

August 29, 2025

Thor Medical and Oncoinvent Enter Strategic Thorium-228 Supply Agreement

August 22, 2025

Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00

Thor Medical logo

Contact
Thor Medical HQ

Drammensveien 167
NO-0277 Oslo, Norway
Org.no: 994 297 422
MVA

+ 47 974 14 000

(08.00-16.00 CET)

post@thormedical.com

Privacy Policy